Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission is to be a leading player in the specialty generic prescription drug market.
We sell a portfolio of prescription topical medicines and a growing number of hospital-based sterile injectable products, including cephalosporins.
Teligent, Inc. Announces 2020 Year-End Earnings Report and Provides Business Update
– Significantly strengthened balance sheet and cash position – Continued FDA Warning Letter remediation efforts – Antici...Learn More
Teligent Announces Hiring of Chief Financial Officer
BUENA, N.J. , April 15, 2021 (GLOBE NEWSWIRE) -- Teligent , Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jer...Learn More
Teligent, Inc. Announces Appointment of Carter Pate to Board of Directors
Experienced Board Member and Investment Executive Joins Teligent, Effective Immediately BUENA, N.J. , Feb. 23, 2021 /PRN...Learn More